Navigation Links
Discovery may explain how prion diseases spread between different types of animals
Date:3/11/2013

Medical researchers at the University of Alberta have made a discovery that may explain how prion diseases, like chronic wasting disease and mad cow disease, adapt in order to spread between various types of animals.

The research team, led by neurologist Valerie Sim, discovered that a miniscule change in the prions' makeup appears to give the disease the ability to adapt to mimic and recreate new strains with which it comes into contact. The team has been studying this area for two years.

"Prion diseases don't always successfully go from one animal to another, but when they do, the process is called adaptation. And we want to figure out what triggers that process to happen, what changes happen within prions to allow the disease to spread," says Sim, a researcher with the Faculty of Medicine & Dentistry, whose discovery was recently published in the peer-reviewed Journal of Biological Chemistry.

"One of the important things researchers in this field have realized is that if you pass certain strains of prion disease through a number of different hosts, the disease can adapt along the way and increase the number of susceptible hosts. That's the big concern right now.

"We want to determine why one prion disease might be able to spread from one type of animal to another and why another strain of the disease can't."

For instance, if a deer with chronic wasting disease is scavenged by another animal, could the prion disease cross into that intermediate host, evolve and then infect animals or species typically not at direct risk for the disease.

"We hope to understand how these bigger issues develop," says Sim. "We need to pay attention to chronic wasting disease in particular because it has the ability to spread in a different way than mad cow disease. Chronic wasting disease prions can be deposited into the soil and stay there for years, and could be eaten by another animal. How does it evolve from there then?"

Sim and her team are continuing their research in this area and are seeing impressive results in the lab reconfirming their findings through the testing of additional models.

Sim works in the Department of Medicine in the Division of Neurology. She is cross-appointed to the Centre for Neuroscience and the Centre for Prions and Protein Folding Diseases.

Her team's research was funded by Alberta Innovates Health Solutions (AIHS), PrioNet Canada and the Alberta Prion Research Institute.

"Dr. Sim's achievements in prion research are of particular significance to Albertans," says Pamela Valentine, Acting CEO of AIHS. "She is truly a world class researcher and we are delighted that our funding was instrumental in recruiting her back to Alberta nearly eight years ago."

The Alberta Prion Research Institute had similar sentiments about the discovery. "We are proud to support Dr. Valerie Sim and her research on prion biology and the mechanisms that lead to prion diseases," said Kevin Keough, Executive Director, Alberta Prion Research Institute (APRI).

"APRI will continue to partner with the Centre for Prion and Protein Folding Diseases and other Alberta-based researchers to focus on research and discoveries that will lead towards diagnoses, treatments and eventual cures of prion and prion-like diseases."

PrioNet Canada agreed: "We are very pleased to have supported Dr. Sim's important work, which is at the forefront of understanding the strange biology of prions," said Neil Cashman, Scientific Director of PrioNet Canada. "Her research will help point the way to predict and manage the deadly impacts of prion diseases."


'/>"/>

Contact: Raquel Maurier
rmaurier@ualberta.ca
780-492-5986
University of Alberta Faculty of Medicine & Dentistry
Source:Eurekalert

Related biology news :

1. Gene discovery reveals importance of eating your greens
2. IU discovery on animal memory opens doors to research on memory impairment diseases
3. Cell discovery could hold key to causes of inherited diseases
4. New scorpion discovery near metropolitan Tucson, Arizona
5. The discovery of a new genus of crustacean and 5 new species
6. A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
7. Discovery of sexual mating in Candida albicans could provide insights into infections
8. New discovery in autism-related disorder reveals key mechanism in brain development and disease
9. Discovery of Africa moth species important for agriculture, controlling invasive plants
10. Discovery may pave way to genetically enhanced biofuel crops
11. LSUHSC research discovery provides therapeutic target for ALS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/13/2016)... April 13, 2016  IMPOWER physicians supporting Medicaid patients ... a new clinical standard in telehealth thanks to a ... the higi platform, IMPOWER patients can routinely track key ... body mass index, and, when they opt in, share ... visit to a local retail location at no cost. ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
(Date:3/23/2016)... , March 23, 2016 ... Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung mit ... Inc. (NASDAQ: MESG ), ein ... dass das Unternehmen mit SpeechPro zusammenarbeitet, um ... der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, im ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... 2016 Apellis Pharmaceuticals, Inc. today announced ... of its complement C3 inhibitor, APL-2. The trials ... dose studies designed to assess the safety, tolerability, ... in healthy adult volunteers. Forty subjects ... single dose (ranging from 45 to 1,440mg) or ...
(Date:6/23/2016)... ... June 23, 2016 , ... ClinCapture, the ... Convention Center and will showcase its product’s latest features from June 26 to ... a scientific poster on Disrupting Clinical Trials in The Cloud during the conference. ...
(Date:6/23/2016)... , June 23, 2016 ... research report to its pharmaceuticals section with historic ... details and much more. Complete report ... 151 pages, profiling 15 companies and supported with ... http://www.reportsnreports.com/reports/601420-global-cell-culture-media-industry-2016-market-research-report.html . The Global ...
Breaking Biology Technology: